LFVN — LifeVantage Corporation

LifeVantage Corporation (LFVN) Q3 2026 Earnings Call Summary

1. Key Financial Results and Metrics:

• Net Revenue: $43.7 million, down 25.2% from $58.4 million in Q3 2025.
• Americas Revenue: Decreased 28.9% to $34.3 million; Asia Pacific and Europe revenue down 7.7% to $9.4 million.
• Gross Profit Margin: 79%, down from 81% year-over-year; adjusted gross profit margin was 79.4%.
• Operating Income: GAAP operating income of $1.7 million (down from $4.1 million); adjusted operating income was $1.8 million.
• Net Income: GAAP net income of $1.4 million ($0.11 per share), down from $3.5 million ($0.26 per share); adjusted net income was $1.5 million ($0.12 per share).
• Adjusted EBITDA: $3.2 million (7.3% of revenues), down from $6.4 million (11%).
• Cash Position: $12.5 million with no debt; generated $5.5 million in cash from operations in the first nine months of 2026.

2. Strategic Updates and Business Highlights:

• Leadership Transition: Michael Beindorff introduced as Interim CEO following Steve Fife's retirement; Terrence Moorhead appointed as new CEO starting August 2026.
• Product Portfolio: Focus on innovative products like Protandim, TruScience Liquid Collagen, and the new Healthy Glow Essentials Stack.
• Consultant Engagement: Launched the VIP bonus program aimed at incentivizing growth and leadership within the consultant community.
• E-commerce Upgrade: Significant investment in upgrading to Shopify to enhance customer and consultant experience.

3. Forward Guidance and Outlook:

• Fiscal 2026 Expectations: Revenue, adjusted EBITDA, and adjusted earnings per share expected to be at the lower end of previous guidance due to ongoing market challenges.
• Long-term Commitment: Focus on operational excellence and strategic growth initiatives to improve profitability metrics.

4. Bad News, Challenges, or Points of Concern:

• Sales Decline: Significant drop in revenue primarily due to decreased sales of the MINDBODY GLP-1 system and a reduction in active consultant accounts.
• Consultant Count: Active consultants in the Americas decreased from 32,000 to 30,000, raising concerns about engagement and retention.
• Increased Expenses: Selling, general, and administrative expenses rose to 31.7% of revenue, attributed to lower sales volume.

5. Notable Q&A Insights:

• Cash Flow: Management expects to maintain positive cash flow in Q4, similar to Q3 performance.
• CapEx: Anticipated steady state of capital expenditures around $1 million per quarter, with potential adjustments post-Shopify implementation.
• Consultant Engagement Strategies: Emphasis on foundational business practices and simplified incentive programs to boost consultant activity.
• Product Development: Upcoming product launch anticipated at the annual convention in October, focusing on science-backed innovations beyond gut health.

Overall, while LifeVantage is facing significant revenue challenges and a decline in active consultants, management remains optimistic about future growth through strategic initiatives and product innovations.